SPY362.06-1.61 -0.44%
DIA296.62-2.62 -0.88%
IXIC12,198.74-7.11 -0.06%

Meridian Bioscience Q4 Adj. EPS $0.19 Beats $0.14 Estimate, Sales $64.20M Beat $59.64M Estimate

Meridian Bioscience (NASDAQ:VIVO) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $0.14 by 35.71 percent. This is a 46.15 percent increase over earnings of $0.13 per share from

· 11/13/2020 07:33
Meridian Bioscience (NASDAQ:VIVO) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $0.14 by 35.71 percent. This is a 46.15 percent increase over earnings of $0.13 per share from the same period last year. The company reported quarterly sales of $64.20 million which beat the analyst consensus estimate of $59.64 million by 7.65 percent. This is a 26.26 percent increase over sales of $50.85 million the same period last year.